Taking on analysts’ expectations and winning: Veritex Holdings Inc (VBTX)

With 0.51 million shares changed hands, the volume of the stock remained heavier than its average volume of 0.45 million shares. The 52-week range on VBTX shows that it touched its highest point at $24.46 and its lowest point at $14.88 during that stretch. It currently has a 1-year price target of $25.00. With its current market cap of 1.09 billion, VBTX has annualized dividend of $0.80 while the current yield stands at 4.00%. Beta for the stock currently stands at 1.34.

Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.

Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!

Get the FREE Report with all the details here.


Sponsored

Price Performance and Earnings:

Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of VBTX was up-trending over the past week, with a rise of 2.51%, but this was up by 1.78% over a month. Three-month performance dropped to -16.78% while six-month performance rose 13.46%. The stock gained 5.71% in the past year, while it has lost -14.14% so far this year. A look at the trailing 12-month EPS for VBTX yields 1.98 with Next year EPS estimates of 2.28. For the next quarter, that number is 0.58. This implies an EPS growth rate of 12.46% for this year and 2.40% for next year. EPS is expected to grow by 7.00% annually over the next five years; however, over the past five years, the company experienced an annual growth rate of 4.39%.

Float and Shares Shorts:

At present, 54.34 million VBTX shares are outstanding with a float of 52.78 million shares on hand for trading. On Mar 15, 2024, short shares totaled 1.44 million, which was 2.64% higher than short shares on Feb 15, 2024. In addition to VKTX as the firm’s Viking Therapeutics, Inc., VRTX serves as its Vertex Pharmaceuticals Incorpor.

Institutional Ownership:

Through their ownership of 90.17% of VBTX’s outstanding shares, institutional investors have majority control over the company.

Analysts Ratings:

Reading analyst opinions is an effective way to decide where to invest, and there are several opinions available for VBTX since 0 analysts follow the stock currently. In the same way, a target price assigned to a stock can also reveal much about its potential.

Dividends & Yield:

In terms of dividends, VBTX has a current ratio of $0.80, which is $0.80 over the trailing 12-months, while a dividend of $– is likely to be paid on average over the next five years. Dividend yield is another indicator that appeals to many investors, and VBTX currently yields $4.01. In the past year, VBTX’s dividend yield has been $4.01, but when looking at the stock over the past five years, its yield has been $2.17. Accordingly, VBTX has a current buyback yield of $0.00. This was $0.00 for the TTM, and it was $– for the past five years.